Results for tag: "Resistant Hypertension Drug"

The Resistant Hypertension Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat high blood pressure, heart failure, and other cardiovascular diseases. Resistant Hypertension Drugs are used to treat patients with hypertension that is not adequately controlled by other medications. These drugs are typically used in combination with other antihypertensive medications, such as diuretics, beta-blockers, and calcium channel blockers. Commonly prescribed Resistant Hypertension Drugs include angiotensin receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACE inhibitors), and direct renin inhibitors (DRIs). Some companies in the Resistant Hypertension Drug market include Pfizer, Novartis, Merck, Sanofi, and AstraZeneca. Show Less Read more